Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 34, 2020 - Issue 2
165
Views
2
CrossRef citations to date
0
Altmetric
Short Communications

Pregnane glycoside from Huernia saudi-arabica as latent schistosomicidal mediator

, , , ORCID Icon &
Pages 311-316 | Received 28 Mar 2018, Accepted 22 Sep 2018, Published online: 08 Nov 2018
 

Abstract

Development of a novel agent for control of schistosomiasis is a mandate. In-vitro anti-schistosomal activity of the aerial parts of Huernia saudi-arabica were examined. Chromatographic investigations of the ethanol extract (EE) were afforded three compounds. Pregnane glycoside (CI) 12-β-p-hydroxy-benzoyl-20-O-acetyl-boucerin-3-O-β-D-glucopyranosyl-(1→4)-β-D-cymaropyranosyl-(1→4)-β-D-cymaropyranoside, in addition to two flavonoids (CII) luteolin-4'-O-β-D-neohesperidoside and (CIII)quercetin-3-rutinoside were recognized via spectral analysis. The schistosomicidal effects were evaluated using scanning electron microscope (SEM). In-vitro bioassays on the viability (mobility, morphological changes and mortality) of Schistosoma mansoni adults, cercariae, miracidia and eggs at different concentrations 2.5, 5, 12.5, 25 and 50 μg/ml of EE and 2.6, 5.2, 13, 26 and 52 μM of CI in incubation times 1,2,4,6,12hrs were carried out. EE and CI evidenced in-vitro anti-schistosomal activity with a dose and incubation time-dependent fashion. The effect of EE and CI was evident by the topography damage showed by SEM. EE proved moderate in-vitro cytotoxicity with IC50 of 8.48 µg/ml.

Graphical Abstract

Disclosure statement

The authors declare that they have no competing interests.

Acknowledgements

Authors would like to thank Dr. Nahid Wally, College of Science, King Abdelaziz University, Jeddah, Saudi Arabia who kindly identified Huernia saudi-arabica plant.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.